Chokeberry extract 'boosts pancreas cancer chemo'

ConclusionIt is now commonly thought that the antioxidants found in fruits and vegetables may have many health benefits, including reducing the risk of some cancers.Pancreatic cancer is a condition with notoriously poor prognosis, and the possibility of any new treatment on the horizon is encouraging. This study found that when pancreatic cancer cells in the laboratory were directly treated with a combination of the chemotherapy drug gemcitabine and chokeberry extract, adding the extract enhanced the cancer-killing potential compared to the chemotherapy drug alone. However, directly adding an extract to cells in the laboratory is a lot different from people actually taking chokeberry extracts themselves. Though these are promising findings, it is too early to say whether the micronutrients found in this extract could be effective in the treatment of pancreatic cancer. Further scientific study will be needed before initial developments could progress to the next stage of trials in people with pancreatic cancer, to see whether chokeberry extract might enhance the effects of chemotherapy.  For now, as experts importantly highlight, people with pancreatic cancer should not consider taking these chokeberry extracts in the form of a herbal remedy or supplement, based on this very early-stage research. Herbal remedies, just like pharmaceutical medicines, will have an effect on the body and can be potentially harmful.They should therefore be used with the same care and respect a...
Source: NHS News Feed - Category: Consumer Health News Tags: Cancer Source Type: news

Related Links:

Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - Category: Cancer & Oncology Source Type: clinical trials
The objective of present study is to investigate the effect of retinoic acid and curcumin –retinoic acid conjugates against GSK-3B protein. The in silico results indicate that molecule 3 (curcumin–retinoic acid conjugates) might be a potent inhibitor of GSK-3B and a novel future drug candidate for the treatment of cancer.
Source: Network Modeling Analysis in Health Informatics and Bioinformatics - Category: Bioinformatics Source Type: research
AbstractAs of late, to enhance the features of serviceability in medical clinic management, medical image processing plays progressive development in conditions of modus operandi and applications. Various techniques are used to diagnosis tumor parts in modern medical image processing with the rising demand in the respective field. In this paper, the detection of the brain tumor and pancreatic tumor using DBCWMF (Decision Based Couple Window Median Filter)algorithm, Statistical region merging (SRM), Cat Swarm Optimization and Scale-invariant feature transform (CSO-SIFT) extraction and classification through Back Propagation...
Source: Health and Technology - Category: Information Technology Source Type: research
Abstract Rapid advance in oncology leads to increasing survival of oncologic patients. More and more of them live long enough to reach either the natural age of menopause or, as a side effect of their oncotherapy, experience the cessation of gonadal function, leading to premature ovarian insufficiency, with disturbing vasomotor symtoms and long-term negative cardiovascular and skeletal effects. Thus, an ever increasing number of cancer survivors search endocrinologic help in the form of hormone replacement therapy (HRT). The misinterpretation of the WHI (Women's Health Initiative) Study has lead to an irrational f...
Source: Pathology Oncology Research - Category: Pathology Authors: Tags: Pathol Oncol Res Source Type: research
Publication date: Available online 1 December 2018Source: European Journal of Surgical OncologyAuthor(s): Luca G. Campana, Ibrahim Edhemovic, Declan Soden, Anna M. Perrone, Marco Scarpa, Laura Campanacci, Maja Cemazar, Sara Valpione, Damijan Miklavčič, Simone Mocellin, Elisabetta Sieni, Gregor SersaAbstractThe treatment of tumors with electrochemotherapy (ECT) has surged over the past decade. Thanks to the transient cell membrane permeabilization induced by the short electric pulses used by ECT, cancer cells are exposed to otherwise poorly permeant chemotherapy agents, with consequent increased cytotoxicity. The codifica...
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
The objective of this study was to determine occurrence of major bleeding as well as recurrent VTE events on treatment with DOACs or LMWHs in a cohort study.Methods: The cancer-associated thrombosis (CAT) clinic is a centralized service for care of cancer patients with suspected deep venous thrombosis (DVT) and/or pulmonary embolism (PE) established at the Tausig Cancer Institute of the Cleveland Clinic. We conducted a prospective cohort study of patients referred to this clinic between 8/2014 through 1/2018. The demographics, cancer types, VTE characteristics, treatment courses, and outcomes (VTE recurrence, major or clin...
Source: Blood - Category: Hematology Authors: Tags: 332. Antithrombotic Therapy: Poster I Source Type: research
Standard-of-care treatment for patients with pleural mesothelioma may soon include Tumor Treating Fields (TTF), a novel therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth. In the wake of recently released results from Novocure’s STELLAR phase II clinical trial, the U.S. Food and Drug Administration (FDA) is expected to approve the treatment within the next six months, giving mesothelioma patients another much-needed option. “At this point, it should be a relatively rapid approval process,” Dr. Eilon Kirson, chief science officer at Novocure, the oncology company...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Authors: Jiang L, Chen S, Zhao D, Yan J, Chen J, Yang C, Zheng G Abstract Glioma is the most common type of malignant intracranial tumor in adults and is associated with the highest mortality rate. Although surgery, radiotherapy, chemotherapy and other treatment methods have progressed, the median survival of patients with glioma is only 14‑15 months. Glioma cells are able to penetrate along blood vessels and invade into the surrounding normal brain tissue so that an overall resection of the tumor cannot be performed. In the process of metastasis, the resistance of cancer cells to anoikis has an important ro...
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
Patients with brain tumor or pancreatic cancer exhibit the poorest prognosis, while immune fitness and cellular immune exhaustion impacts their survival immensely. This work identifies differences in the immun...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Research Source Type: research
The idea that viruses may be co-opted to do good rather than harm isn’t entirely new; researchers have been attempting to harness the power of viruses and bacteria for more than a century. Vaccines are the shining example of using bad bugs to do good in priming the immune system to fight disease. But disease-causing viruses aren’t always easy to corral, and attempts to use them to activate the immune system against things other than fellow bacteria and viruses — including cancer, for example — have not been so successful. There is only one approved virus-based treatment for cancer, which uses herpes...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cancer healthytime Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Complementary Medicine | Education | Health | Herbs | Laboratory Medicine | Neurology | Nutrition | Pancreas | Pancreatic Cancer | Pathology | Science | Study | Universities & Medical Training